Health Care & Life Sciences » Pharmaceuticals | Ritter Pharmaceuticals Inc.

Ritter Pharmaceuticals Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
2.10
3.50
1.90
5.20
5.70
5.70
Gross Income
2.10
3.50
1.90
5.20
5.70
5.70
SG&A Expense
2,108.70
2,278.10
8,906.50
18,441.50
7,896.80
16,989.80
EBIT
2,110.80
2,281.60
8,908.40
18,446.70
7,902.50
16,995.60
Non Operating Income/Expense
19.40
21.20
79.80
1.20
1.60
-
Interest Expense
6.10
213.50
-
-
-
-
Pretax Income
2,095.80
2,473.50
8,787.80
18,384.60
7,863.90
16,868.70
Consolidated Net Income
2,095.80
2,473.50
8,787.80
18,384.60
7,863.90
16,868.70
Net Income
2,095.80
2,473.50
8,787.80
18,384.60
7,863.90
16,868.70
Net Income After Extraordinaries
2,095.80
2,473.50
8,787.80
18,384.60
7,863.90
16,868.70
Net Income Available to Common
2,643.10
3,071.50
9,178.60
18,384.60
10,974.90
19,406.60
EPS (Basic)
3.39
3.94
31.10
20.40
5.00
3.66
Basic Shares Outstanding
778.80
778.80
294.70
899.30
2,215.00
5,304.70
EPS (Diluted)
3.39
3.94
31.15
20.44
4.95
3.66
Diluted Shares Outstanding
778.80
778.80
294.70
899.30
2,215.00
5,304.70
EBITDA
2,108.70
2,278.10
8,906.50
18,441.50
7,896.80
16,989.90
Non-Operating Interest Income
1.70
0.50
40.90
60.90
40.20
126.80
Preferred Dividends
547.30
598.00
390.90
-
3,111.00
2,537.80

About Ritter Pharmaceuticals

View Profile
Address
1880 Century Park East
Los Angeles California 90067
United States
Employees -
Website http://www.ritterpharmaceuticals.com
Updated 07/08/2019
Ritter Pharmaceuticals, Inc. engages in the development of novel therapeutic products which modulate the human gut microbiome to treat gastrointestinal diseases. It focuses on the development and commercialization of RP-G28. The company was founded by Andrew J.

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.